Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-03

Clinical Trial Update: A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled mannitol in adult cystic fibrosis patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mannitol (inhaled) (mannitol)

Snippet

Sponsor: Syntara | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-03